Early research (Phase 1)Ended earlyNCT03799003What this trial is testingASP1951 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Astellas Pharma Global Development, Inc. 119
Not applicableWithdrawnNCT05175092What this trial is testingLiving Donor Liver Transplantation for CRC Liver MetastasesWho this might be right forLiver Metastasis Colon Cancer University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00008294What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01040000What this trial is testingQUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerWho this might be right forMetastatic Pancreatic CancerMetastatic Colorectal Cancer Precision Biologics, Inc 94
Testing effectiveness (Phase 2)Ended earlyNCT05039944What this trial is testingSI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System MalignanciesWho this might be right forColorectal Cancer Sichuan Baili Pharmaceutical Co., Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT01053013What this trial is testingOpen-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal CancerWho this might be right forPancreatic Adenocarcinoma Non-resectablePancreatic Adenocarcinoma MetastaticColorectal Cancer Metastatic The Rogosin Institute 58
Large-scale testing (Phase 3)Study completedNCT01721954What this trial is testingFOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal CancerWho this might be right forColorectal Cancer Metastatic Sirtex Medical 209
Large-scale testing (Phase 3)Looking for participantsNCT07702032What this trial is testingStudy of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)Who this might be right forLeft-sided Colorectal Cancer Genmab 960
Large-scale testing (Phase 3)Looking for participantsNCT06185556What this trial is testingCOLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver MetastasesWho this might be right forColorectal CancerLiver MetastasesLiver Metastasis Colon Cancer+1 more Amsterdam UMC, location VUmc 78
Testing effectiveness (Phase 2)Ended earlyNCT04844073What this trial is testingTAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic CancerWho this might be right forSquamous Cell Cancer of Head and Neck (SCCHN)Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer Takeda 95
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Looking for participantsNCT06555003What this trial is testingDEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver MetastasesWho this might be right forLiver NeoplasmColorectal Cancer Metastatic Tehran University of Medical Sciences 116
Large-scale testing (Phase 3)Not Yet RecruitingNCT06616259What this trial is testingFirst-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III StudyWho this might be right forColorectal Cancer (CRC)CapecitabineCetuximab Meng Qiu 452
Testing effectiveness (Phase 2)UnknownNCT04508452What this trial is testingA Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRCWho this might be right forUnresectable Metastatic Colorectal Carcinoma First Affiliated Hospital of Zhejiang University 91
Large-scale testing (Phase 3)Looking for participantsNCT06750094What this trial is testingAmivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyWho this might be right forColorectal Neoplasms Janssen Research & Development, LLC 700
Early research (Phase 1)Study completedNCT03095781What this trial is testingPembrolizumab and XL888 in Patients With Advanced Gastrointestinal CancerWho this might be right forColorectal AdenocarcinomaMetastatic Pancreatic AdenocarcinomaRecurrent Colorectal Carcinoma+12 more Emory University 47
Testing effectiveness (Phase 2)Ended earlyNCT01715363What this trial is testingFeasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal CancerWho this might be right forPatients With Colorectal Cancer With Unresectable Synchronous Metastasis in Whom Resection of the Primitive Tumour is Indicated Gustave Roussy, Cancer Campus, Grand Paris 3
Large-scale testing (Phase 3)Study completedNCT02314182What this trial is testingGRECCAR 8: Primary Tumor Resection in Rectal Cancer With Unresectable MetastasisWho this might be right forRectal Adenocarcinoma Hospices Civils de Lyon 5
Early research (Phase 1)Looking for participantsNCT03692429What this trial is testingAlloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cellsWho this might be right forUnresectable Metastatic Colorectal Cancer Celyad Oncology SA 49